1.database Pubmed

DATABASE PUBMED
( MICROBIOTA STUNTED/STUNTING )
1. Influence of gut microbiota on neuropsychiatric disorders.

2. Microbiota Transfer Therapy alters gut ecosystem and improves
gastrointestinal and autism symptoms: an open-label study.
3. Gut microbiota and gastric disease.
4. Duodenal Microbiota in Stunted Undernourished Children with
Enteropathy.
5. Factors affecting early-life intestinal microbiota development.
6. Relationship between intestinal microbiota and ulcerative colitis:
Mechanisms and clinical application of probiotics and
fecal microbiota transplantation.
7. The Relationship Between the Serotonin Metabolism, Gut-Microbiota and
the Gut-Brain Axis.
8. Effects of microbiota-directed foods in gnotobiotic animals and
undernourished children.
9. Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain.
10. Stunted microbiota and opportunistic pathogen colonization in caesarean-
section birth.
11. The role of the gut microbiota in development, function and disorders of
the central nervous system and the enteric nervous system.
12. The gut microbiome and the brain.
13. The Central Nervous System and the Gut Microbiome.
14. Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and
Gut Hormones.
15. Exercise influence on the microbiome-gut-brain axis.
16. Dynamics and Stabilization of the Human Gut Microbiome during the First
Year of Life.
17. Microbiota and neurodevelopmental windows: implications for
brain disorders.
18. Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-
Gut-Lung Triangle.
19. PPARs and Microbiota in Skeletal Muscle Health and Wasting.
20. Environmental Enteric Dysfunction and Growth Failure/Stunting in Global
Child Health.
21. Intestinal IgA as a modulator of the gut microbiota.
22. Gut microbiota remodeling reverses aging-associated inflammation and
dysregulation of systemic bile acid homeostasis in mice sex-specifically.
23. The gut microbiota: An emerging risk factor for cardiovascular and
cerebrovascular disease.
24. Control of lupus nephritis by changes of gut microbiota.
25. Development of the Pediatric Gut Microbiome: Impact on Health and
Disease.
26. Gut bacteria that prevent growth impairments transmitted
by microbiota from malnourished children.
27. Persistent gut microbiota immaturity in malnourished Bangladeshi children.
28. Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.
29. Akkermansia muciniphila and its role in regulating host functions.
30. AGA Clinical Practice Guidelines on the Role of Probiotics in the
Management of Gastrointestinal Disorders.
31. Modulation of Gut Microbiota Composition by Serotonin Signaling
Influences Intestinal Immune Response and Susceptibility to Colitis.
32. Our Gut Microbiome: The Evolving Inner Self.
33. Interactions between gut microbiota and skeletal muscle.
34. High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and
Metabolic Disorders in Mice without Body Weight Change.
35. Intervention strategies for cesarean section-induced alterations in
the microbiota-gut-brain axis.
36. Probiotic supplements might not be universally-effective and safe: A review.
37. Immunotoxicity and intestinal effects of nano- and microplastics: a review of
the literature.
38. Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-
Neotetraose (LNnT) in Infant Formula.
39. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and
glucose intolerance by modulating bile acid metabolism in hamsters.
40. Pathogenesis and post-infectious complications in giardiasis.
41. Early nutrition and gut microbiome: interrelationship between bacterial
metabolism, immune system, brain structure, and neurodevelopment.
42. The Perturbance of Microbiome and Gut-Brain Axis in Autism
Spectrum Disorders.
43. Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of
the Gut Microbiota on Brain and Behavior.
44. Vitamin D signaling maintains intestinal innate immunity and
gut microbiota: potential intervention for metabolic syndrome and NAFLD.
45. Connection between gut microbiome and brain development in preterm
infants.
46. The effect of fiber and prebiotics on children's gastrointestinal disorders and
microbiome.
47. The canine gastrointestinal microbiota: early studies and research frontiers.
48. Gut microbiota: puppeteer of the host juvenile growth.
49. Turning the "Phage" on Malnutrition and Stunting.
50. Gut commensal Parabacteroides goldsteinii plays a predominant role in the
anti-obesity effects of polysaccharides isolated from Hirsutella sinensis.
51. Does the Gut Microbiota Modulate Host Physiology through Polymicrobial
Biofilms?
52. Molecular mechanisms of the rapid-acting and long-lasting antidepressant
actions of (R)-ketamine.
53. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex
hormone related gut microbiota.
54. Does the gut microbiota contribute to the oligodendrocyte progenitor
niche?
55. Annual Research Review: Critical windows - the microbiota-gut-brain axis in
neurocognitive development.
56. Environmental enteric dysfunction pathways and child stunting: A systematic
review.
57. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of
major colorectal disorders.
58. [Gut microbiota in health and disease].
59. Non-Melanoma Skin Cancer: news from microbiota research.
60. Food matters: how the microbiome and gut-brain interaction might impact
the development and course of anorexia nervosa.
61. AGA Technical Review on the Role of Probiotics in the Management of
Gastrointestinal Disorders.
62. Signs and symptoms associated with digestive tract development.
63. Microbiota-Sourced Purines Support Wound Healing and Mucous Barrier
Function.
64. Childhood undernutrition, the gut microbiota, and microbiota-directed
therapeutics.
65. Assessing the Intestinal Microbiota in the SHINE Trial.
66. Butyrate producing colonic Clostridiales metabolise human milk
oligosaccharides and cross feed on mucin via conserved pathways.
67. Prebiotic inulin-type fructans and galacto-oligosaccharides: definition,
specificity, function, and application in gastrointestinal disorders.
68. Impact of nasopharyngeal microbiota on the development of respiratory
tract diseases.
69. Intestinal microbiota, diet and health.
70. Interactions of probiotics and prebiotics with the gut microbiota.
71. Microbiota on biotics: probiotics, prebiotics, and synbiotics to
optimize growth and metabolism.
72. Programming Bugs: Microbiota and the Developmental Origins of Brain
Health and Disease.
73. Regulation of barrier immunity and homeostasis by integrin-mediated
transforming growth factor beta activation.
74. Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-
like Symptoms in Mice by Expanding Akkermansia muciniphila.
75. Changes in Faecal Microbiota Profiles Associated With Performance and
Birthweight of Piglets.
76. Standardized Preparation for Fecal Microbiota Transplantation in Pigs.
77. Intestinal microbial dysbiosis aggravates the progression of
Alzheimer's disease in Drosophila.
78. Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.
79. The Microbiota and Malnutrition: Impact of Nutritional Status During Early
Life.
80. Upper gastrointestinal microbiota and digestive diseases.
81. Microbiota - a key to healing the gastrointestinal tract?
82. Reframing the Teenage Wasteland: Adolescent Microbiota-Gut-Brain Axis.
83. Comparison of Healthy and Dandruff Scalp Microbiome Reveals the Role of
Commensals in Scalp Health.
84. What's bugging your teen?-The microbiota and adolescent mental health.
85. Factors affecting the composition of the gut microbiota, and its modulation.
86. [Intestinal microbiota, nutrients and probiotics viewed from the "gut-lung"
axis].
87. An increase in the Akkermansia spp. population induced by metformin
treatment improves glucose homeostasis in diet-induced obese mice.
88. Gut-Amygdala Interactions in Autism Spectrum Disorders: Developmental
Roles via regulating Mitochondria, Exosomes, Immunity and microRNAs.
89. [Current view on gut microbiota].
90. Differential modulation by Akkermansia muciniphila and Faecalibacterium
prausnitzii of host peripheral lipid metabolism and histone acetylation in
mouse gut organoids.
91. Carbohydrates and the human gut microbiota.
92. Altered diversity and composition of gut microbiota in Wilson's disease.
93. Dynamic changes in intestinal microbiota in young forest musk deer during
weaning.
94. A Budding Relationship: Bacterial Extracellular Vesicles in the Microbiota-
Gut-Brain Axis.
95. Microbiota and Neurodevelopmental Trajectories: Role of Maternal and
Early-Life Nutrition.
96. Bile acid is a significant host factor shaping the gut microbiome of diet-
induced obese mice.
97. Bile Acid Supplementation Improves Murine Pancreatitis in Association With
the Gut Microbiota.
98. Growth promotion and gut microbiota: insights from antibiotic use.
99. Stress and the Microbiota-Gut-Brain Axis: An Evolving Concept in Psychiatry.
100. Comorbidity between depression and inflammatory bowel disease explained
by immune-inflammatory, oxidative, and nitrosative stress; tryptophan
catabolite; and gut-brain pathways.
101. Prebiotic intake reduces the waking cortisol response and alters emotional
bias in healthy volunteers.
102. Gut microbiota alterations and dietary modulation in childhood malnutrition
- The role of short chain fatty acids.
103. Decreased maternal serum acetate and impaired fetal thymic and regulatory
T cell development in preeclampsia.
104. Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors.
105. The Gut Microbiota: A Promising Target in the Relation between
Complementary Feeding and Child Undernutrition.
106. Danggui Buxue Tang restores antibiotic-induced metabolic disorders by
remodeling the gut microbiota.
107. A diet-microbial metabolism feedforward loop modulates intestinal stem cell
renewal in the stressed gut.
108. The MAL-ED study: a multinational and multidisciplinary approach to
understand the relationship between enteric pathogens, malnutrition, gut
physiology, physical growth, cognitive development, and immune responses
in infants and children up to 2 years of age in resource-poor environments.
109. Staphylococcus aureus and the Cutaneous Microbiota Biofilms in the
Pathogenesis of Atopic Dermatitis.
110. Neohesperidin attenuates obesity by altering the composition of the
gut microbiota in high-fat diet-fed mice.
111. Environmental Enteric Dysfunction and the Fecal Microbiota in Malawian
Children.
112. Vertical transmission of gut microbiota: Points of action of environmental
factors influencing brain development.
113. [Human Intestinal Microbiota: Role in Development and Functioning of the
Nervous System].
114. The effects of inflammation, infection and antibiotics on the microbiota-gut-
brain axis.
115. Plant extracts as natural modulators of gut microbiota community structure
and functionality.
116. Dietary iron variably modulates assembly of the intestinal microbiota in
colitis-resistant and colitis-susceptible mice.
117. Antibiotics in early life and obesity.
118. Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and
Intestinal Homeostasis in Mice Fed a Low-Protein Diet.
119. Prebiotics and Community Composition Influence Gas Production of the
Human Gut Microbiota.
120. Does gut microbiome associate with the growth of infants? A review of the
literature.
121. Alterations in the Urinary Microbiota Are Associated With Cesarean Delivery.
122. Berberine treatment increases Akkermansia in the gut and improves high-fat
diet-induced atherosclerosis in Apoe-/- mice.
123. At the Intersection of Microbiota and Circadian Clock: Are Sexual
Dimorphism and Growth Hormones the Missing Link to Pathology?:
Circadian Clock and Microbiota: Potential Egffect on Growth Hormone and
Sexual Development.
124. Bile acid sequestration reverses liver injury and prevents progression of
nonalcoholic steatohepatitis in Western diet-fed mice.
125. Disrupted tongue microbiota and detection of nonindigenous bacteria on
the day of allogeneic hematopoietic stem cell transplantation.
126. Gut microbiota: Growth impairment in undernourished children.
127. Mushrooms Bioactive as Prebiotics to Modulate Gut Microbiota in
Relationships with Causes and Prevention of Liver Diseases (Review).
128. Dysbiosis in Functional Bowel Disorders.
129. Gut Microbiome and Infant Health: Brain-Gut-Microbiota Axis and Host
Genetic Factors.
130. Gut microbiota of newborn piglets with intrauterine growth restriction have
lower diversity and different taxonomic abundances.
131. [Characterization of the microbiota and cytokine profile of sperm plasma in
men with chronic bacterial prostatitis].
132. Gut Microbiota Features Associated With Campylobacter Burden and
Postnatal Linear Growth Deficits in a Peruvian Birth Cohort.
133. Giardia duodenalis induces pathogenic dysbiosis of human
intestinal microbiota biofilms.
134. Overview of paediatric IBD.
135. Stunting Is Preceded by Intestinal Mucosal Damage and Microbiome
Changes and Is Associated with Systemic Inflammation in a Cohort of
Peruvian Infants.
136. Longitudinal Analysis of the Intestinal Microbiota in
Persistently Stunted Young Children in South India.
137. A distinct gut microbiota composition in patients with ankylosing
spondylitis is associated with increased levels of fecal calprotectin.
138. Association of faecal pH with childhood stunting: Results from a cross-
sectional study.
139. Gut microbiota controls adipose tissue expansion, gut barrier and glucose
metabolism: novel insights into molecular targets and interventions using
prebiotics.
140. Identifying the etiology and pathophysiology underlying stunting and
environmental enteropathy: study protocol of the AFRIBIOTA project.
141. [Mechanism of gut-microbiota-liver axis in the pathogenesis of intestinal
failure-associated liver disease].
142. Inflammatory bowel disease: role of diet, microbiota, life style.
143. Contextual risk factors impacting the colonization and development of the
intestinal microbiota: Implications for children in low- and middle-income
countries.
144. Possibilities of early life programming in broiler chickens via
intestinal microbiota modulation.
145. Microbial and nutritional influence on endocrine control of growth.
146. Bacteriophages Isolated from Stunted Children Can Regulate Gut Bacterial
Communities in an Age-Specific Manner.
147. Mechanisms and effectiveness of prebiotics in modifying the
gastrointestinal microbiota for the management of digestive disorders.
148. MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic
phenotype.
149. Environmental Chemical Diethylhexyl Phthalate Alters
Intestinal Microbiota Community Structure and Metabolite Profile in Mice.
150. Long-term Proton Pump Inhibitor Administration Caused Physiological
and Microbiota Changes in Rats.
151. Host Immunity to Malassezia in Health and Disease.
152. Oesophageal atresia: The growth gap.
153. Impact of vitamin deficiency on microbiota composition and
immunomodulation: relevance to autistic spectrum disorders.
154. The Gut Microbiome in Child Malnutrition.
155. Stable Isotope Techniques for the Assessment of Host
and Microbiota Response During Gastrointestinal Dysfunction.
156. Huai hua san alleviates dextran sulphate sodium-induced colitis and
modulates colonic microbiota.
157. The Physiology and Mechanism of Growth.
158. Microbiota-derived lipopolysaccharide retards chondrocyte hypertrophy in
the growth plate through elevating Sox9 expression.
159. Study of the fetal and maternal microbiota in pregnant women with
intrauterine growth restriction and its relationship with inflammatory
biomarkers: A case-control study protocol (SPIRIT compliant).
160. Composition of gut microbiota in infants in China and global comparison.
161. Rice bran supplementation modulates growth, microbiota and metabolome
in weaning infants: a clinical trial in Nicaragua and Mali.
162. Phytohormones: Multifunctional nutraceuticals against metabolic syndrome
and comorbid diseases.
163. A Retrospective Case-Control Study of the Relationship between the
Gut Microbiota, Enteropathy, and Child Growth.
164. The Microbiota-Gut-Brain Axis: From Motility to Mood.
165. The gut microbiome.
166. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease
by modulating gut microbiota, improving intestinal barrier integrity, and
attenuating inflammation.
167. Assessment of Neonatal Intensive Care Unit Practices and Preterm Newborn
Gut Microbiota and 2-Year Neurodevelopmental Outcomes.
168. The role of prebiotics in cognition, anxiety, and depression.
169. Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting
Children.
170. Gut microbiota profile of Indonesian stunted children and children with
normal nutritional status.
171. Absence of gut microbiota influences lipopolysaccharide-induced
behavioral changes in mice.
172. Could the beneficial effects of dietary calcium on obesity and diabetes
control be mediated by changes in intestinal microbiota and integrity?
173. Effects of subchronic exposure of mercuric chloride on intestinal histology
and microbiota in the cecum of chicken.
174. Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for
Diagnosis and Treatment.
175. Modulation of Placental Gene Expression in Small-for-Gestational-Age
Infants.
176. Fructose malabsorption syndrome.
177. New insights into environmental enteric dysfunction.
178. Environmental enteric dysfunction and growth.
179. Green Tea Encourages Growth of Akkermansia muciniphila.
180. Bacteriophages in food supplements obtained from natural sources.
181. Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and
co-morbidities: role of gastrointestinal microbiota.
182. Amino Acids Regulate Glycolipid Metabolism and Alter Intestinal Microbial
Composition.
183. Analysis of temporal fecal microbiota dynamics in weaner pigs with and
without exposure to enterotoxigenic Escherichia coli1,2.
184. Proof-of-concept study of the efficacy of a microbiota-directed
complementary food formulation (MDCF) for treating moderate acute
malnutrition.
185. Aflatoxins: Occurrence, Exposure, and Binding to Lactobacillus Species from
the Gut Microbiota of Rural Ugandan Children.
186. Malnutrition and Catch-Up Growth during Childhood and Puberty.
187. Severe gut microbiota dysbiosis caused by malnourishment can be partly
restored during 3 weeks of refeeding with fortified corn-soy-blend in a piglet
model of childhood malnutrition.
188. Dysbiotic microbiota in autistic children and their mothers: persistence of
fungal and bacterial wall-deficient L-form variants in blood.
189. Maternal and infant factors that shape neonatal gut colonization by bacteria.
190. Decoding breast milk oligosaccharides.
191. Can we reduce autism-related gastrointestinal and behavior problems by
gut microbiota based dietary modulation? A review.
192. CBirTox is a selective antigen-specific agonist of the Treg-IgA-
microbiota homeostatic pathway.
193. The impact of in utero HIV exposure on gut microbiota, inflammation, and
microbial translocation.
194. Alginate oligosaccharide improves lipid metabolism and inflammation by
modulating gut microbiota in high-fat diet fed mice.
195. Compound Lactobacillus sp. administration ameliorates stress and
body growth through gut microbiota optimization on weaning piglets.
196. Immunoglobulin recognition of fecal bacteria in stunted and non-
stunted children: findings from the Afribiota study.
197. [The value of mucosal small intestine microbiota in digestion and
absorption disorders in metabolic syndrome].
198. The protective effects of walnut green husk polysaccharide on liver injury,
vascular endothelial dysfunction and disorder of gut microbiota in high
fructose-induced mice.
199. Sialylated Milk Oligosaccharides Promote Microbiota-Dependent Growth in
Models of Infant Undernutrition.
200. What's eating you? An update on Giardia, the microbiome and the immune
response.
201. Mechanisms of obesity-induced gastrointestinal neoplasia.
203. Inflammation and the microbiome: implications for depressive disorders.
204. Environmental enteric dysfunction: an overview.
205. Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders.
206. Childhood malnutrition and the intestinal microbiome.
207. beta-Carotene prevents weaning-induced intestinal inflammation by
modulating gut microbiota in piglets.
208. Evolution, human-microbe interactions, and life history plasticity.
209. Effects of the acid-base treatment of corn on rumen fermentation
and microbiota, inflammatory response and growth performance in beef
cattle fed high-concentrate diet.
210. Microbiome programming of brain development: implications for
neurodevelopmental disorders.
211. Effects of a Synbiotic Formula on Functional Bowel Disorders and
Gut Microbiota Profile during Long-Term Home Enteral Nutrition (LTHEN): A
Pilot Study.
212. Potential Impacts of Prebiotics and Probiotics in Cancer Prevention.
213. Lactobacillus casei improves depression-like behavior in chronic
unpredictable mild stress-induced rats by the BDNF-TrkB signal pathway and
the intestinal microbiota.
214. Microbiome, growth retardation and metabolism: are they related?
215. Host-microbe interactions via membrane transport systems.
216. Early-Life Nutrition and Microbiome Development.
217. Characteristics of the gut microbiota colonization, inflammatory profile, and
plasma metabolome in intrauterine growth restricted piglets during the first
12 hours after birth.
218. Gut microbiota profiles of young South Indian children: Child sex-specific
relations with growth.
219. Does the Oral Microbiome Play a Role in Hypertensive Pregnancies?
220. Participation of the intestinal microbiota in the mechanism of beneficial
effect of treatment with synbiotic Syngut on experimental colitis under stress
conditions.
221. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism
and alters gut microbiota composition in hyperlipidemic mice fed a high-fat
diet.
222. Polyphenols as modulators of pre-established gut microbiota dysbiosis:
State-of-the-art.
223. The immunomodulatory role of bile acids.
224. Pig models on intestinal development and therapeutics.
225. Emerging issues in complementary feeding: Global aspects.
226. Gut microbiota varies by opioid use, circulating leptin and oxytocin in
African American men with diabetes and high burden of chronic disease.
227. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
228. Implication of gut microbiota in human health.
229. In vitro modulation of gut microbiota by whey protein to preserve intestinal
health.
230. Modulating the microbiota in inflammatory bowel diseases: prebiotics,
probiotics or faecal transplantation?
231. Emulating Host-Microbiome Ecosystem of Human Gastrointestinal Tract in
Vitro.
232. Fecal microbiota analysis of children with small intestinal bacterial
overgrowth among residents of an urban slum in Brazil.
233. Linear growth faltering in infants is associated with Acidaminococcus sp. and
community-level changes in the gut microbiota.
234. Gut biofilm forming bacteria in inflammatory bowel disease.
235. Bacterial skin commensals and their role as host guardians.
236. The gut microflora assay in patients with colorectal cancer: in feces or tissue
samples?
237. Current Understanding of Innate Immune Cell Dysfunction in Childhood
Undernutrition.
238. Voices from within: gut microbes and the CNS.
Enteropathy. Reply.
240. Microbiomes Reduce Their Host's Sensitivity to Interspecific Interactions.
241. Maternal administration of probiotics promotes gut development in mouse
offsprings.
Enteropathy.
Enteropathy.
244. Severe Gut Microbiota Dysbiosis Is Associated With Poor Growth in Patients
With Short Bowel Syndrome.
245. Developments in the study of gastrointestinal
microbiome disorders affected by FGF19 in the occurrence and
development of colorectal neoplasms.
246. Loss of PTPN22 abrogates the beneficial effect of cohousing-mediated
fecal microbiota transfer in murine colitis.
247. [INFECTIOUS SYMBIOLOGY].
248. Microbiome: Eating for trillions.
249. Beneficial Effects of Non-Encapsulated or Encapsulated Probiotic
Supplementation on Microbiota Composition, Intestinal Barrier Functions,
Inflammatory Profiles, and Glucose Tolerance in High Fat Fed Rats.
250. Astaxanthin (ATX) enhances the intestinal mucosal functions in
immunodeficient mice.
251. Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver
disease.
252. Gut microbiota dysbiosis is associated with malnutrition and reduced
plasma amino acid levels: Lessons from genome-scale metabolic modeling.
253. Scalp bacterial shift in Alopecia areata.
254. Age-associated Impairment of the Mucus Barrier Function is Associated with
Profound Changes in Microbiota and Immunity.
255. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of
Diabetes Mellitus.
256. Lactococcus lactis and Resveratrol Decrease Body Weight and Increase
Benefic Gastrointestinal Microbiota in Mice.
257. Helicobacter pylori and its relationship with variations of gut microbiota in
asymptomatic children between 6 and 12 years.
258. Microbiota control of maternal behavior regulates early postnatal growth of
offspring.
259. The role of the gut microbiome in mediating neurotoxic outcomes to PCB
exposure.
260. Assessment of the adverse impacts of aflatoxin B(1) on gut-
microbiota dependent metabolism in F344 rats.
261. Early-life enteric infections: relation between chronic systemic inflammation
and poor cognition in children.
262. Food restriction followed by refeeding with a casein- or whey-based diet
differentially affects the gut microbiota of pre-pubertal male rats.
263. The impact of Helicobacter pylori infection on gut microbiota-endocrine
system axis; modulation of metabolic hormone levels and energy
homeostasis.
264. What's in the pipeline for lower functional gastrointestinal disorders in the
next 5 years?
265. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut
microbiology.
266. Gut Microbiota Disorders Promote Inflammation and Aggravate Spinal
Cord Injury Through the TLR4/MyD88 Signaling Pathway.
267. Finding intestinal fortitude: Integrating the microbiome into a holistic view of
depression mechanisms, treatment, and resilience.
268. Medicinal lavender modulates the enteric microbiota to protect against
Citrobacter rodentium-induced colitis.
269. Mechanisms of cross-talk between the diet, the intestinal microbiome, and
the undernourished host.
270. Changes in microbial ecology after fecal microbiota transplantation for
recurrent C. difficile infection affected by underlying inflammatory bowel
disease.
271. Differences in the Gut Microbiota Establishment and Metabolome
Characteristics Between Low- and Normal-Birth-Weight Piglets During Early-
Life.
272. [Changes in the composition of intestinal microbiota in mice with acute liver
failure induced by D-galactosamine].
273. Bacterial Diversity of Intestinal Microbiota in Patients with Substance
Use Disorders Revealed by 16S rRNA Gene Deep Sequencing.
274. [Role of the microbiome in chronic wounds].
275. Early development of the gut microbiome and immune-mediated
childhood disorders.
276. Animal Models of Undernutrition and Enteropathy as Tools for Assessment
of Nutritional Intervention.
277. Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular
Diseases.
278. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes
in response of colocytes.
279. Enduring Behavioral Effects Induced by Birth by Caesarean Section in the
Mouse.
280. Sulfated polysaccharides from Undaria pinnatifida improved high fat diet-
induced metabolic syndrome, gut microbiota dysbiosis and inflammation in
BALB/c mice.
281. Overgrowth of the indigenous gut microbiome and irritable bowel
syndrome.
282. Biomarkers to Stratify Risk Groups among Children with Malnutrition in
Resource-Limited Settings and to Monitor Response to Intervention.
283. Neonatal environment exerts a sustained influence on the development of
the intestinal microbiota and metabolic phenotype.
284. Effect of prebiotic and probiotic supplementation on neurodevelopment in
preterm very low birth weight infants: findings from a meta-analysis.
285. Arc1 and the microbiota together modulate growth and metabolic traits in
Drosophila.
286. Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of
Children with Suspected or Diagnosed Autism Spectrum Disorders and In
Vitro Susceptibility Against Nystatin and Fluconazole.
287. Eosinophils in Homeostasis and Their Contrasting Roles during Inflammation
and Helminth Infections.
288. Lysosome-Rich Enterocytes Mediate Protein Absorption in the Vertebrate
Gut.
289. Hygiene and other early childhood influences on the subsequent function of
the immune system.
290. Ginseng ameliorates exercise-induced fatigue potentially by regulating the
gut microbiota.
291. Early-life adversity and brain development: Is the microbiome a missing
piece of the puzzle?
292. Metabolic tinkering by the gut microbiome: Implications for brain
development and function.
293. Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile
Acid Production and Allow for Clostridium difficile Spore Germination and
Outgrowth in the Large Intestine.
294. Pasteurized Akkermansia muciniphila protects from fat mass gain but not
from bone loss.
295. An introduction of the role of probiotics in human infections and
autoimmune diseases.
296. The human microbiome and the great obstetrical syndromes: a new frontier
in maternal-fetal medicine.
297. Dental biofilm and its ecological interrelationships in ovine periodontitis.
298. Microbes & neurodevelopment--Absence of microbiota during early life
increases activity-related transcriptional pathways in the amygdala.
299. The inflammatory event of birth: How oxytocin signaling may guide the
development of the brain and gastrointestinal system.
300. Microbial Impact on Host Metabolism: Opportunities for Novel Treatments
of Nutritional Disorders?
301. Intergenerational Influences between Maternal Polycystic Ovary Syndrome
and Offspring: An Updated Overview.
302. Prebiotics and probiotics: their role in the management of
gastrointestinal disorders in adults.
303. Diarrhea as a Potential Cause and Consequence of Reduced Gut Microbial
Diversity Among Undernourished Children in Peru.
304. Dietary Lactobacillus plantarum ST-III alleviates the toxic effects of triclosan
on zebrafish (Danio rerio) via gut microbiota modulation.
305. 3-(4-Hydroxy-3-methoxyphenyl)propionic Acid Produced from 4-Hydroxy-3-
methoxycinnamic Acid by Gut Microbiota Improves Host Metabolic
Condition in Diet-Induced Obese Mice.
306. Nanoplastics impair the intestinal health of the juvenile large yellow croaker
Larimichthys crocea.
307. Biological significance of short-chain fatty acid metabolism by the intestinal
microbiome.
308. Transforming growth factor and intestinal inflammation: the role of
nutrition.
309. Colonization with the enteric protozoa Blastocystis is associated with
increased diversity of human gut bacterial microbiota.
310. Impact of Flavonoids on Cellular and Molecular Mechanisms Underlying
Age-Related Cognitive Decline and Neurodegeneration.
311. Huangjinya Black Tea Alleviates Obesity and Insulin Resistance via
Modulating Fecal Metabolome in High-Fat Diet-Fed Mice.
312. An evolving perspective about the origins of childhood undernutrition and
nutritional interventions that includes the gut microbiome.
313. Antibiotic-mediated modification of the intestinal microbiome in allogeneic
hematopoietic stem cell transplantation.
314. Diagnosis of small intestinal bacterial overgrowth in the clinical practice.
315. Gut microbiota: stunted gut microbiota development persists after
therapeutic food interventions in children with severe acute malnutrition.
316. Effects of Dietary Interventions on Gut Microbiota in Humans and the
Possible Impacts of Foods on Patients' Responses to Cancer Immunotherapy.
317. Production of germ-free mosquitoes via transient colonisation allows stage-
specific investigation of host-microbiota interactions.
318. Fat binding capacity and modulation of the gut microbiota both determine
the effect of wheat bran fractions on adiposity.
319. Microbial insight into dietary protein source affects intestinal function of pigs
with intrauterine growth retardation.
320. Could Nodding Syndrome (NS) in Northern Uganda be an environmentally
induced alteration of ancestral microbiota?
321. Microbiome: Restoring healthy growth in infants.
322. Radiomicrobiomics: Advancing Along the Gut-brain Axis Through Big Data
Analysis.
323. Growth velocity in children with Environmental Enteric Dysfunction is
associated with specific bacterial and viral taxa of the gastrointestinal tract in
Malawian children.
324. IgA synthesis: a form of functional immune adaptation extending beyond
gut.
325. Campylobacter jejuni and associated immune mechanisms: short-term
effects and long-term implications for infants in low-income countries.
326. Evidence-based interventions for improvement of maternal and child
nutrition in low-income settings: what's new?
327. [Microbiota of urine and vagina of healthy postmenopausal women (a pilot
study)].
328. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence
and Expectations for Gut Microbiome Transplantation.
329. Neonatal Enteropathogenic Escherichia coli Infection Disrupts Microbiota-
Gut-Brain Axis Signaling.
330. Amino acid metabolism in intestinal bacteria and its potential implications
for mammalian reproduction.
331. Impact of dietary induced precocious gut maturation on
cecal microbiota and its relation to the blood-brain barrier during the
postnatal period in rats.
332. Markers of Environmental Enteric Dysfunction Are Associated with
Poor Growth and Iron Status in Rural Ugandan Infants.
333. Recipe for a Healthy Gut: Intake of Unpasteurised Milk Is Associated with
Increased Lactobacillus Abundance in the Human Gut Microbiome.
334. Fecal dysbiosis in infants with cystic fibrosis is associated with early
linear growth failure.
335. Common beans and cowpeas as complementary foods to reduce
environmental enteric dysfunction and stunting in Malawian children: study
protocol for two randomized controlled trials.
336. Lactobacillus plantarum NCU116 attenuates cyclophosphamide-induced
intestinal mucosal injury, metabolism and intestinal microbiota disorders in
mice.
337. Interactions of Dietary Fibre with Nutritional Components on Gut Microbial
Composition, Function and Health in Monogastrics.
338. Review: Mouse models of inflammatory bowel disease--insights into the
mechanisms of inflammation-associated colorectal cancer.
339. Sex dependent effects of post-natal penicillin on brain, behavior and
immune regulation are prevented by concurrent probiotic treatment.
340. Mechanisms by which sialylated milk oligosaccharides impact bone biology
in a gnotobiotic mouse model of infant undernutrition.
341. Lactobacillus rhamnosus Granules Dose-Dependently Balance Intestinal
Microbiome Disorders and Ameliorate Chronic Alcohol-Induced Liver Injury.
342. Intestinal Dysbiosis Correlates With Sirolimus-induced
Metabolic Disorders in Mice.
343. Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the
Brain Amyloid-β in Tg2576 Mice.
344. The effect of dietary resistant starch type 2 on the microbiota and markers
of gut inflammation in rural Malawi children.
345. Cationic Polystyrene Resolves Nonalcoholic Steatohepatitis, Obesity, and
Metabolic Disorders by Promoting Eubiosis of Gut Microbiota and
Decreasing Endotoxemia.
346. Microbiome. The right gut microbes help infants grow.
347. Metabolome and microbiome alterations related to short-term feeding of a
micronutrient-fortified, high-quality legume protein-based food product
to stunted school age children: A randomized controlled pilot trial.
348. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis
and insulin resistance in association with modulation of gut microbiota in
mice.
349. Co-occurrence of Campylobacter Species in Children From Eastern Ethiopia,
and Their Association With Environmental Enteric Dysfunction, Diarrhea, and
Host Microbiome.
350. Early life nutrition influences susceptibility to chronic inflammatory colitis in
later life.
351. The Double Burden of Malnutrition Calls for Better Diet Quality Worldwide.
352. Plant Prebiotics and Their Role in the Amelioration of Diseases.
353. Developmental exposure of California mice to endocrine disrupting
chemicals and potential effects on the microbiome-gut-brain axis at
adulthood.
354. TNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate
Spontaneous Sex-Biased Central Nervous System Demyelinating
Autoimmune Disease.
355. Trace metals and animal health: Interplay of the gut microbiota with iron,
manganese, zinc, and copper.
356. A mixture of trans-galactooligosaccharides reduces markers of metabolic
syndrome and modulates the fecal microbiota and immune function of
overweight adults.
357. The "systems approach" to treating the brain: opportunities in
developmental psychopharmacology.
358. Dietary soybean protein concentrate-induced intestinal disorder in marine
farmed Atlantic salmon, Salmo salar is associated with alterations in
gut microbiota.
359. Lactobacillus rhamnosus lowers zebrafish lipid content by changing
gut microbiota and host transcription of genes involved in lipid metabolism.
360. Effects of synbiotic supplementation on gut microbiome, serum level of TNF-
α, and expression of microRNA-126 and microRNA-146a in patients with
type 2 diabetes mellitus: study protocol for a double-blind controlled
randomized clinical trial.
361. Bifidobacterium longum subsp. longum Remodeled Roseburia and
Phosphatidylserine Levels and Ameliorated Intestinal Disorders and liver
Metabolic Abnormalities Induced by High-Fat Diet.
362. Endocrine disrupting chemicals and metabolic disorders in the liver: What if
we also looked at the female side?
363. Predictive Metagenomic Profiling, Urine Metabolomics, and Human Marker
Gene Expression as an Integrated Approach to Study Alopecia Areata.
364. Cognitive and Microbiome Impacts of Experimental Ancylostoma ceylanicum
Hookworm Infections in Hamsters.
365. Feed intake limitation strategies for the growing rabbit: effect on feeding
behaviour, welfare, performance, digestive physiology and health: a review.
366. Effects of the Cistanche tubulosa Aqueous Extract on the Gut Microbiota of
Mice with Intestinal Disorders.
367. Dietary Cellulose Supplementation Modulates the Immune Response in a
Murine Endotoxemia Model.
368. Inflammatory Bowel Disease: Effects on Bone and Mechanisms.
369. Association between extrauterine growth restriction and changes of
intestinal flora in Chinese preterm infants.
370. Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of
Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study.
371. Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in
association with modulation of gut microbiota in mice.
372. N-Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in
high-fat diet-fed mice.
373. Subtle selectivity in a pheromone sensor triumvirate desynchronizes
competence and predation in a human gut commensal.
374. The intestinal virome of malabsorption syndrome-affected and unaffected
broilers through shotgun metagenomics.
375. Intestinal response characteristic and potential microbial dysbiosis in
digestive tract of Bufo gargarizans after exposure to cadmium and lead,
alone or combined.
376. Pediatric small intestine bacterial overgrowth in low-income countries.
377. The probiotic Lactobacillus fermentum 296 attenuates
cardiometabolic disorders in high fat diet-treated rats.
378. Pathobiome driven gut inflammation in Pakistani children with
Environmental Enteric Dysfunction.
379. Adolescent diabetes induced by multiple parental exposures to cigarette
smoke condensate.
380. Examination of Host Phenotypes in Gambusia affinis Following Antibiotic
Treatment.
381. High-methionine diet in skeletal muscle remodeling: epigenetic mechanism
of homocysteine-mediated growth retardation.
382. It's in the Milk: Feeding the Microbiome to Promote Infant Growth.
383. Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains
Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in
Animal Models.
384. Comprehensive Bibliometric Analysis of the Kynurenine Pathway in
Mood Disorders: Focus on Gut Microbiota Research.
385. The Influence of Cesarean Section on the Composition and Development of
Gut Microbiota During the First 3 Months of Life.
386. Impact of feed restriction on health, digestion and faecal microbiota of
growing pigs housed in good or poor hygiene conditions.
387. Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon
Cancer.
388. Contribution of "Omic" Studies to the Understanding of Cadasil. A
Systematic Review.
389. Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous
model of multiple sclerosis.
390. Intestinal dysbiosis: an emerging cause of pregnancy complications?
391. Bacterial Succession in the Broiler Gastrointestinal Tract.
392. The effect of bovine colostrum/egg supplementation compared with
corn/soy flour in young Malawian children: a randomized, controlled clinical
trial.
393. Potential role of weather, soil and plant microbial communities in rapid
decline of apple trees.
394. Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis
on Immune Regulation.
395. An Exposome Perspective on Environmental Enteric Dysfunction.
396. Effects of maize rotation on the physicochemical properties and microbial
communities of American ginseng cultivated soil.
397. Effects of dietary supplementation of selenium-enriched probiotics on
production performance and intestinal microbiota of weanling piglets raised
under high ambient temperature.
398. Bacterial sensing underlies artificial sweetener-induced growth of gut
Lactobacillus.
399. Intestinal fluke Metagonimus yokogawai infection increases probiotic
Lactobacillus in mouse cecum.
400. Polysaccharides from fermented Momordica charantia L. with Lactobacillus
plantarum NCU116 ameliorate metabolic disorders and
gut microbiota change in obese rats.
401. Chinese liver fluke Clonorchis sinensis infection changes the gut microbiome
and increases probiotic Lactobacillus in mice.
402. Relative abundance of Akkermansia spp. and other bacterial phylotypes
correlates with anxiety- and depressive-like behavior following social defeat
in mice.
403. Effect of Native and Acetylated Dietary Resistant Starches on Intestinal
Fermentative Capacity of Normal and Stunted Children in Southern India.
404. Postnatal growth retardation is associated with deteriorated intestinal
mucosal barrier function using a porcine model.
405. Fetal exposure to maternal inflammation interrupts murine intestinal
development and increases susceptibility to neonatal intestinal injury.
406. Is small intestinal bacterial overgrowth involved in the pathogenesis of
functional dyspepsia?
407. Astragalus Polysaccharides Ameliorate Diet-Induced Gallstone Formation by
Modulating Synthesis of Bile Acids and the Gut Microbiota.
408. Lactobacillus fermentum NS9 restores the antibiotic induced physiological
and psychological abnormalities in rats.
409. Akkermansia muciniphila strain ATCC BAA-835 does not promote short-term
intestinal inflammation in gnotobiotic interleukin-10-deficient mice.
410. Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of
Cyclooxygenase-2 by Rofecoxib in the Rat.
411. Guadipyr, a new insecticide, induces microbiota dysbiosis and
immune disorders in the midgut of silkworms (Bombyx mori).
412. Physiological and Metabolic Effects of Yellow Mangosteen (Garcinia dulcis)
Rind in Rats with Diet-Induced Metabolic Syndrome.
413. Plant and Animal-Type Feedstuff Shape the Gut Microbiota and Metabolic
Processes of the Chinese Mitten Crab Eriocheir sinensis.
414. Intestinal nerve cell injury occurs prior to insulin resistance in female mice
ingesting a high-fat diet.
415. Influence of Socio-Economic and Psychosocial Profiles on the Human Breast
Milk Bacteriome of South African Women.
416. Significance of African Diets in Biotherapeutic Modulation of the Gut
Microbiome.
417. Study of Environmental Enteropathy and Malnutrition (SEEM) in Pakistan:
protocols for biopsy based biomarker discovery and validation.
418. Size-dependent adverse effects of microplastics on intestinal microbiota and
metabolic homeostasis in the marine medaka (Oryzias melastigma).
419. Anxiety-like behavior and intestinal microbiota changes as strain-and sex-
dependent sequelae of mild food allergy in mouse models of cow's milk
allergy.
420. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation
and hypercholesterolaemia in high-fat diet-induced obese mice: potential
implication of the gut microbiota.
421. The effect of antibiotics on social aversion following early life inflammation.
422. Early-life high-fat diet-induced obesity programs hippocampal development
and cognitive functions via regulation of gut commensal Akkermansia
muciniphila.
423. The composition and structure of the intestinal microflora of Anguilla
marmorata at different growth rates: a deep sequencing study.
424. Alterations in the Vaginal Microbiome by Maternal Stress Are Associated
With Metabolic Reprogramming of the Offspring Gut and Brain.
425. Lysozyme-rich milk mitigates effects of malnutrition in a pig model of
malnutrition and infection.
426. Preparation and preservation of viable Akkermansia muciniphila cells for
therapeutic interventions.
427. Increased Urinary Trimethylamine N-Oxide Following Cryptosporidium
Infection and Protein Malnutrition Independent of Microbiome Effects.
428. Effects of dietary Lactobacillus rhamnosus JCM1136 and Lactococcus lactis
subsp. lactis JCM5805 on the growth, intestinal microbiota, morphology,
immune response and disease resistance of juvenile Nile tilapia, Oreochromis
niloticus.
429. Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide
Utilization by Intestinal Lactobacillus rhamnosus.
430. Perturbations of gut microbiome genes in infants with atopic dermatitis
according to feeding type.
431. Dietary modulation of the microbiome affects autoinflammatory disease.
432. The critical roles of iron during the journey from fetus to adolescent:
Developmental aspects of iron homeostasis.
433. Stunted childhood growth is associated with decompartmentalization of the
gastrointestinal tract and overgrowth of oropharyngeal taxa.
434. Bifidobacterium infantis M-63 improves mental health in victims with irritable
bowel syndrome developed after a major flood disaster.
435. Generation of axenic Aedes aegypti demonstrate live bacteria are not
required for mosquito development.
436. Assessment of Environmental Enteric Dysfunction in the SHINE Trial:
Methods and Challenges.
437. Etiology of Diarrhea, Nutritional Outcomes, and Novel Intestinal Biomarkers
in Tanzanian Infants.
438. Maternal Weaning Modulates Emotional Behavior and Regulates the Gut-
Brain Axis.
439. Effect of cryopreservation and lyophilization on viability and growth of strict
anaerobic human gut microbes.
440. Flaxseed oil supplementation improves intestinal function and immunity,
associated with altered intestinal microbiome and fatty acid profile in pigs
with intrauterine growth retardation.
441. Antioxidant properties of formula derived Maillard reaction products in
colons of intrauterine growth restricted pigs.
442. The Impact of Gut Microbiome on Metabolic Disorders During Catch-
Up Growth in Small-for-Gestational-Age.
443. Chronic consequences on human health induced by microbial
pathogens: Growth faltering among children in developing countries.
444. Faecalibacterium prausnitzii (ATCC 27766) has preventive and therapeutic
effects on chronic unpredictable mild stress-induced depression-like and
anxiety-like behavior in rats.
445. From pre- to postweaning: Transformation of the young
calf's gastrointestinal tract.
446. Environmental characteristics of a tundra river system in Svalbard. Part 2:
Chemical stress factors.
447. Adaptation of commensal proliferating Escherichia coli to the intestinal tract
of young children with cystic fibrosis.
448. Adverse effect of early-life high-fat/high-carbohydrate ("Western") diet on
bacterial community in the distal bowel of mice.
449. Gutting the brain of inflammation: A key role of gut microbiome in human
umbilical cord blood plasma therapy in Parkinson's disease model.
450. The Role of Gut Bacterial Metabolites in Brain Development, Aging and
Disease.
451. Nurturing gut-brain research: an interview with Helen Vuong on the maternal
microbiome in neurodevelopment.
452. A postbiotic consisting of heat-treated lactobacilli has a bifidogenic effect in
pure culture and in human fermented faecal communities.
453. n-6 High Fat Diet Induces Gut Microbiome Dysbiosis and Colonic
Inflammation.
454. Remnant Small Bowel Length in Pediatric Short Bowel Syndrome and the
Correlation with Intestinal Dysbiosis and Linear Growth.
455. Effects of Subchronic Copper Poisoning on Cecal Histology and Its Microflora
in Chickens.
456. Risk factors for noma disease: a 6-year, prospective, matched case-control
study in Niger.
457. [Disorders of gut microflora in the pathogenesis of liver cirrhosis and
complications of portal hypertension].
458. Characterizing the metabolic phenotype of intestinal villus blunting in
Zambian children with severe acute malnutrition and persistent diarrhea.
459. Utilization of major fucosylated and sialylated human milk oligosaccharides
by isolated human gut microbes.
460. Prenatal stress affects placental cytokines and neurotrophins, commensal
microbes, and anxiety-like behavior in adult female offspring.
461. Wholegrain oat-based cereals have prebiotic potential and low glycaemic
index.
462. Does Dysbiosis Increase the Risk of Developing Schizophrenia? - A
Comprehensive Narrative Review.
463. Effects of dietary Lactobacillus rhamnosus CF supplementation on growth,
meat quality, and microenvironment in specific pathogen-free chickens.
464. Gut dysbiosis and impairment of immune system homeostasis in perinatally-
exposed mice to Bisphenol A precede obese phenotype development.
465. Bangladesh Environmental Enteric Dysfunction (BEED) study: protocol for a
community-based intervention study to validate non-invasive biomarkers of
environmental enteric dysfunction.
466. Long-term effects of heavy metals and antibiotics on granule-based
anammox process: granule property and performance evolution.
467. Diabetic cognitive dysfunction is associated with increased bile acids in liver
and activation of bile acid signaling in intestine.
468. Isolation and characterization of an agaro-oligosaccharide (AO)-hydrolyzing
bacterium from the gut microflora of Chinese individuals.
469. Symbiotic Human Gut Bacteria with Variable Metabolic Priorities for Host
Mucosal Glycans.
470. Strategies to promote abundance of Akkermansia muciniphila, an emerging
probiotics in the gut, evidence from dietary intervention studies.
471. Environmental enteric dysfunction induces regulatory T cells that inhibit local
CD4+ T cell responses and impair oral vaccine efficacy.
472. In vitro fermentation of B-GOS: impact on faecal bacterial populations and
metabolic activity in autistic and non-autistic children.
473. Mixed conjugated linoleic acid sex-dependently reverses high-fat diet-
induced insulin resistance via the gut-adipose axis.
474. Effects of the Dietary Protein and Carbohydrate Ratio on Gut Microbiomes in
Dogs of Different Body Conditions.
475. The Role of Milk Protein and Whey Permeate in Lipid-based Nutrient
Supplements on the Growth and Development of Stunted Children in
Uganda: A Randomized Trial Protocol (MAGNUS).
476. Vitamin A and Retinoic Acid Exhibit Protective Effects on Necrotizing
Enterocolitis by Regulating Intestinal Flora and Enhancing the
Intestinal Epithelial Barrier.
477. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to
colonic sensory and motor changes in mice.
478. EFFECT OF CARBOXYLIC ACIDS OF GUT MICROBIAL ORIGIN ON HOST CELL
PROLIFERATION IN ORGANOTYPIC TISSUE CULTURES.
479. Excessive Unbalanced Meat Consumption in the First Year of Life Increases
Asthma Risk in the PASTURE and LUKAS2 Birth Cohorts.
480. Lactobacillus plantarum Strain Ln4 Attenuates Diet-Induced Obesity, Insulin
Resistance, and Changes in Hepatic mRNA Levels Associated with Glucose
and Lipid Metabolism.
481. Copper-induced sublethal effects in Bufo gargarizans tadpoles: growth,
intestinal histology and microbial alternations.
482. Inflammation fuels colicin Ib-dependent competition of Salmonella serovar
Typhimurium and E. coli in enterobacterial blooms.
483. Biotransformation and in vitro metabolic profile of bioactive extracts from a
traditional Miao-nationality herbal medicine, Polygonum capitatum.
484. Effects of intrauterine growth retardation and Bacillus subtilis PB6
supplementation on growth performance, intestinal development and
immune function of piglets during the suckling period.
485. Anti-Allergic Diarrhea Effect of Diosgenin Occurs via Improving Gut Dysbiosis
in a Murine Model of Food Allergy.
486. Impact of feed restriction and housing hygiene conditions on specific and
inflammatory immune response, the cecal bacterial community and the
survival of young rabbits.
487. Dietary Nucleotides Supplementation Improves the Intestinal Development
and Immune Function of Neonates with Intra-Uterine Growth Restriction in a
Pig Model.
488. A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and
Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples.
489. An agent-based modeling framework for evaluating hypotheses on risks for
developing autism: effects of the gut microbial environment.
490. Protein Malnutrition Modifies Innate Immunity and Gene Expression by
Intestinal Epithelial Cells and Human Rotavirus Infection in Neonatal
Gnotobiotic Pigs.
491. Effects of S24-7 on the weight of progeny rats after exposure to ceftriaxone
sodium during pregnancy.
492. Changes in the intestinal bacterial community, short-chain fatty acid profile,
and intestinal development of preweaned Holstein calves. 1. Effects of
prebiotic supplementation depend on site and age.
493. A gut microbial metabolite of ginsenosides, compound K, induces intestinal
glucose absorption and Na(+) /glucose cotransporter 1 gene expression
through activation of cAMP response element binding protein.
494. Inulin Supplementation Lowered the Metabolic Defects of Prolonged
Exposure to Chlorpyrifos from Gestation to Young Adult Stage in Offspring
Rats.
495. Neonatal antibiotic exposure impairs child growth during the first six years
of life by perturbing intestinal microbial colonization.
496. Prevalence and antimicrobial resistance profiles of respiratory microbial flora
in African children with HIV-associated chronic lung disease.
497. Differences in immune status and fecal SCFA between
Indonesian stunted children and children with normal nutritional status.
498. Wheat bran extract alters colonic fermentation and microbial composition,
but does not affect faecal water toxicity: a randomised controlled trial in
healthy subjects.
499. [Antagonistic activity of lactobacilli of the colon].
500. Prevalence of autoantibodies against some selected growth and appetite-
regulating neuropeptides in serum of short children exposed to Candida
albicans colonization and/or Helicobacter pylori infection: the molecular
mimicry phenomenon.
501. Prospecting prebiotics, innovative evaluation methods, and their health
applications: a review.
502. Inhibitory Effect of a Microecological Preparation on Azoxymethane/Dextran
Sodium Sulfate-Induced Inflammatory Colorectal Cancer in Mice.
503. Impact of diet on human gut microbiome and disease risk.
504. Microbial Therapeutics Designed for Infant Health.
505. [Dynamics of contamination and persistence of Clostridium difficile in
intestinal microbiota in newborn infants during antibiotic therapy and use of
probiotic strain enterococcus faecium L3].
506. Potential benefits of colostrum in gastrointestinal diseases.
507. Diversity of bacterial communities on the facial skin of different age-group
Thai males.
508. The influence of nutrition on clinical outcomes in children with cancer.
509. Role of PHGG as a dietary fiber: a review article.
510. Epigenetic Influences on Neurodevelopment at 11 Years of Age: Protocol for
the Longitudinal Peri/Postnatal Epigenetic Twins Study at 11 Years of Age
(PETS@11).
511. Ambient pH regulates secretion of lipases in Malassezia furfur.
512. Effect of a synbiotic on microbial community structure in a continuous
culture model of the gastric microbiota in enteral nutrition patients.
513. Nutrients Mediate Bioavailability and Turnover of Proteins in Mammals.
514. Interplay Between Gut Microbiota and Gastrointestinal Peptides: Potential
Outcomes on the Regulation of Glucose Control.
515. Association between Bioactive Molecules in Breast Milk and Type 1 Diabetes
Mellitus.
516. A simple, semiselective medium for anaerobic isolation of anginosus group
streptococci from patients with chronic lung disease.
517. Transplanting fecal material from wild-type mice fed black raspberries alters
the immune system of recipient mice.
518. Gut microbiome composition is linked to whole grain-induced
immunological improvements.
519. Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and
the underlying mechanism.
520. Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice.
521. Screening of Probiotic Candidates in Human Oral Bacteria for the Prevention
of Dental Disease.
522. Trimebutine as a potential antimicrobial agent: a preliminary in vitro
approach.
523. Sodium butyrate alleviates cholesterol gallstones by regulating bile acid
metabolism.
524. Chili Peppers, Curcumins, and Prebiotics in Gastrointestinal Health and
Disease.
525. Lactobacillus fermentum L930BB and Bifidobacterium animalis subsp.
animalis IM386 initiate signalling pathways involved in intestinal epithelial
barrier protection.
526. Influence of Feeding Omega-3 Polyunsaturated Fatty Acids to Broiler
Breeders on Indices of Immunocompetence, Gastrointestinal, and Skeletal
Development in Broiler Chickens.
527. Bovine milk oligosaccharides decrease gut permeability and improve
inflammation and microbial dysbiosis in diet-induced obese mice.
528. Melatonin Alleviates Neuroinflammation and Metabolic Disorder in DSS-
Induced Depression Rats.
529. Crosstalk between the growth hormone/insulin-like growth factor-1 axis
and the gut microbiome: A new frontier for microbial endocrinology.
530. Clostridium Bacteria and Autism Spectrum Conditions: A Systematic Review
and Hypothetical Contribution of Environmental Glyphosate Levels.
531. Update on FXR Biology: Promising Therapeutic Target?
532. Sex differences in metabolism and cardiometabolic disorders.
533. Probiotic mixture of Lactobacillus helveticus R0052 and Bifidobacterium
longum R0175 attenuates hippocampal apoptosis induced by
lipopolysaccharide in rats.
534. Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal
tract.
535. Elevation of the vitreous body concentrations of oxidative stress-responsive
apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy.
536. Molecular and Lifestyle Factors Modulating Obesity Disease.
537. Mechanisms behind the link between obesity and gastrointestinal cancers.
538. Gut microbial activity, implications for health and disease: the potential role
of metabolite analysis.
539. Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential
Biomarker or New Therapeutic Target.
540. Pathways Connecting Late-Life Depression and Dementia.
541. The Potential Relevance of the Microbiome to Hair Physiology and
Regeneration: The Emerging Role of Metagenomics.
542. A Mathematical Model for the Hydrogenotrophic Metabolism of Sulphate-
Reducing Bacteria.
543. Engineered probiotic and prebiotic nutraceutical supplementations in
combating non-communicable disorders: A review.
544. Nutritional impact on health and performance in intensively reared rabbits.
545. Dietary squid ink polysaccharides ameliorated the intestinal microflora
dysfunction in mice undergoing chemotherapy.
546. Clinical Management of the Microbiome in Irritable Bowel Syndrome.
547. NOD-like receptors in intestinal homeostasis and epithelial tissue repair.
548. Effect of probiotic and prebiotic vs placebo on psychological outcomes in
patients with major depressive disorder: A randomized clinical trial.
549. Long-term safety of early consumption of Lactobacillus fermentum
CECT5716: A 3-year follow-up of a randomized controlled trial.
550. Critical Role of Zinc in a New Murine Model of Enterotoxigenic Escherichia
coli Diarrhea.
551. Role of Helicobacter pylori and Other Environmental Factors in the
Development of Gastric Dysbiosis.
552. The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With
Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled
Study.
553. Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes
in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept
Affects Serum and Urine Metabolic Profiles.
554. Pathway-based approaches to the treatment of inflammatory bowel disease.
555. Characterization of native Escherichia coli populations from bovine vagina of
healthy heifers and cows with postpartum uterine disease.
556. Development of a Genome-Scale Metabolic Model and Phenome Analysis of
the Probiotic Escherichia coli Strain Nissle 1917.
557. Tissue-resident memory Th17 cells maintain stable fungal commensalism in
the oral mucosa.
558. Unraveling the Complexity of Soil Microbiomes in a Large-Scale Study
Subjected to Different Agricultural Management in Styria.
559. COLOSTRO NONI administration effects on epithelial cells turn-over,
inflammatory events and integrity of intestinal mucosa junctional systems.
560. Bifidobacterium animalis: the missing link for the cancer-preventive effect
of Gynostemma pentaphyllum.
561. Diabetic gastrointestinal motility disorders and the role of enteric nervous
system: current status and future directions.
562. Early-life malnutrition causes gastrointestinal dysmotility that is sexually
dimorphic.
563. The Effect of Administration of a Phytobiotic Containing Cinnamon Oil and
Citric Acid on the Metabolism, Immunity, and Growth Performance of Broiler
Chickens.
564. Converging effects of a Bifidobacterium and Lactobacillus probiotic strain on
mouse intestinal physiology.
565. Campylobacter jejuni increases flagellar expression and adhesion of
noninvasive Escherichia coli: effects on enterocytic Toll-like receptor 4 and
CXCL-8 expression.
566. Functional Bowel Disorders Are Associated with a Central Immune
Activation.
567. Biofilm formation, adherence, and hydrophobicity of M. sympodialis, M.
globosa, and M. slooffiae from clinical isolates and normal skinVirulence
factors of M. sympodialis, M. globosa and M. slooffiae.
568. Ozone: a natural bioactive molecule with antioxidant property as potential
new strategy in aging and in neurodegenerative disorders.
569. Neonatal gut and immune maturation is determined more by postnatal age
than by postconceptional age in moderately preterm pigs.
570. Sugarcane molasses enhances TGF-β secretion and FOXP3 gene expression
by Bifidobacterium Animalis Subsp. Lactis stimulated PBMCs of Ulcerative
Colitis patients.
571. Preparation and Optimization of Moxifloxacin Microspheres for Colon
Targeted Delivery Using Quality by Design Approach: In Vitro and In Vivo
Study.
572. The influence of probiotic supplementation on gut permeability in patients
with metabolic syndrome: an open label, randomized pilot study.
573. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting
Paneth cell production of α-defensins.
574. Obesity-associated mechanisms of hepatocarcinogenesis.
575. Raspberry pomace alters cecal microbial activity and reduces secondary bile
acids in rats fed a high-fat diet.
576. Prostate cancer management: long-term beliefs, epidemic developments in
the early twenty-first century and 3PM dimensional solutions.
577. Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia
through the microbiome-gut-organs axis in db/db mice.
578. Immune precision medicine for cancer: a novel insight based on the
efficiency of immune effector cells.
579. Human Milk Oligosaccharides Inhibit Candida albicans Invasion of Human
Premature Intestinal Epithelial Cells.
580. The Brain-Gut-Microbiome Axis.
581. Neovaginoplasty Using Nile Tilapia Fish Skin as a New Biologic Graft in
Patients with Mayer-Rokitansky-Küster-Hauser Syndrome.
582. Therapeutic and Industrial Applications of Curdlan With Overview on Its
Recent Patents.
583. Untargeted Metabolomics Reveals Intestinal Pathogenesis and Self-Repair in
Rabbits Fed an Antibiotic-Free Diet.
584. Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium
Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to
induced barrier hyper-permeability in mice.
585. Measuring Artificial Sweeteners Toxicity Using a Bioluminescent Bacterial
Panel.
586. Obesity and Liver Cancer.
587. Subversion of Systemic Glucose Metabolism as a Mechanism to Support
the Growth of Leukemia Cells.
588. Urolithin B suppresses tumor growth in hepatocellular carcinoma through
inducing the inactivation of Wnt/beta-catenin signaling.
589. Antimicrobial and Physicochemical Properties of Artificial Saliva Formulations
Supplemented with Core-Shell Magnetic Nanoparticles.
590. Colonic inflammation accompanies an increase of β-catenin signaling and
Lachnospiraceae/Streptococcaceae bacteria in the hind gut of high-fat diet-
fed mice.
591. Evidence of altered mucosa-associated and fecal microbiota composition in
patients with Irritable Bowel Syndrome.
592. Profiles of urine and blood metabolomics in autism spectrum disorders.
593. Dynamic role of single-celled fungi in ruminal microbial ecology and
activities.
594. A purified membrane protein from Akkermansia muciniphila or the
pasteurized bacterium improves metabolism in obese and diabetic mice.
595. Bee pollen and propolis improve neuroinflammation and dysbiosis induced
by propionic acid, a short chain fatty acid in a rodent model of autism.
596. RUBIC (ReproUnion Biobank and Infertility Cohort): A binational clinical
foundation to study risk factors, life course, and treatment of infertility and
infertility-related morbidity.
597. Abstracts from the 3rd International Genomic Medicine Conference (3rd
IGMC 2015) : Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December
2015.
DATABASE PUBMED
( GUT MICROBIOTA STUNTED CHILDREN)
1. Microbiota Transfer Therapy alters gut ecosystem and
improves gastrointestinal and autism symptoms: an open-label study.
2. Duodenal Microbiota in Stunted Undernourished Children with Enteropathy.
5. Dynamics and Stabilization of the Human Gut Microbiome during the First Year
of Life.
6. Gut bacteria that prevent growth impairments transmitted by microbiota from
malnourished children.
8. Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-
Lung Triangle.
9. Development of the Pediatric Gut Microbiome: Impact on Health and Disease.
10. Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.
11. Environmental Enteric Dysfunction and Growth Failure/Stunting in
Global Child Health.
12. Gut microbiota profile of Indonesian stunted children and children with normal
nutritional status.
13. Intervention strategies for cesarean section-induced alterations in the microbiota-
gut-brain axis.
14. Does the gut microbiota contribute to the oligodendrocyte progenitor niche?
17. Microbiota and neurodevelopmental windows: implications for brain disorders.
18. The effect of fiber and prebiotics
on children's gastrointestinal disorders and microbiome.
19. Food matters: how the microbiome and gut-brain interaction might impact the
development and course of anorexia nervosa.
therapeutics.
24. The MAL-ED study: a multinational and multidisciplinary approach to understand
the relationship between enteric pathogens, malnutrition, gut physiology,
physical growth, cognitive development, and immune responses in infants
and children up to 2 years of age in resource-poor environments.
26. Gut microbiota alterations and dietary modulation in childhood malnutrition -
The role of short chain fatty acids.
29. Effects of Serotonin and Slow-Release 5-Hydroxytryptophan
on Gastrointestinal Motility in a Mouse Model of Depression.
30. A Retrospective Case-Control Study of the Relationship between
the Gut Microbiota, Enteropathy, and Child Growth.
31. Gut-Amygdala Interactions in Autism Spectrum Disorders: Developmental Roles
via regulating Mitochondria, Exosomes, Immunity and microRNAs.
32. AGA Technical Review on the Role of Probiotics in the Management
of Gastrointestinal Disorders.
33. Gut microbiota: stunted gut microbiota development persists after therapeutic
food interventions in children with severe acute malnutrition.
38. Gut microbiota dysbiosis is associated with malnutrition and reduced plasma
amino acid levels: Lessons from genome-scale metabolic modeling.
41. Measuring Artificial Sweeteners Toxicity Using a Bioluminescent Bacterial Panel.
43. Gut Microbiota Features Associated With Campylobacter Burden and Postnatal
Linear Growth Deficits in a Peruvian Birth Cohort.
45. Pathobiome driven gut inflammation in Pakistani children with Environmental
Enteric Dysfunction.
47. Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC
2015) : Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015.
49. Can we reduce autism-related gastrointestinal and behavior problems
by gut microbiota based dietary modulation? A review.
50. Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell
development in preeclampsia.
51. Intestinal Microbiota in Common Chronic
Inflammatory Disorders Affecting Children.
52. Assessment of Neonatal Intensive Care Unit Practices and Preterm
Newborn Gut Microbiota and 2-Year Neurodevelopmental Outcomes.
53. Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples
of Children with Suspected or Diagnosed Autism Spectrum Disorders and In
55. Environmental Enteric Dysfunction and the Fecal Microbiota in
Malawian Children.
56. The effect of dietary resistant starch type 2 on the microbiota and markers
of gut inflammation in rural Malawi children.
countries.
65. Impact of nasopharyngeal microbiota on the development of respiratory tract
diseases.
67. The Microbiota and Malnutrition: Impact of Nutritional Status During Early Life.
77. Severe gut microbiota dysbiosis caused by malnourishment can be partly restored
during 3 weeks of refeeding with fortified corn-soy-blend in a piglet model of
childhood malnutrition.
81. Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of
Nutritional Disorders?
82. Effects of a Synbiotic Formula on Functional
Bowel Disorders and Gut Microbiota Profile during Long-Term Home Enteral
Nutrition (LTHEN): A Pilot Study.
83. Mechanisms of cross-talk between the diet, the intestinal microbiome, and the
undernourished host.
84. Association of faecal pH with childhood stunting: Results from a cross-sectional
study.
85. Neonatal Enteropathogenic Escherichia coli Infection Disrupts Microbiota-Gut-
Brain Axis Signaling.
87. Stunting Is Preceded by Intestinal Mucosal Damage and Microbiome Changes
and Is Associated with Systemic Inflammation in a Cohort of Peruvian Infants.
dimorphic.
89. Stunted childhood growth is associated with decompartmentalization of
the gastrointestinal tract and overgrowth of oropharyngeal taxa.
90. Hygiene and other early childhood influences on the subsequent function of the
immune system.
91. Co-occurrence of Campylobacter Species in Children From Eastern Ethiopia, and
Their Association With Environmental Enteric Dysfunction, Diarrhea, and
Host Microbiome.
92. Early-life enteric infections: relation between chronic systemic inflammation and
poor cognition in children.
95. Proof-of-concept study of the efficacy of a microbiota-directed complementary
food formulation (MDCF) for treating moderate acute malnutrition.
Undernutrition.
98. Animal Models of Undernutrition and Enteropathy as Tools for Assessment of
Nutritional Intervention.
101. Mechanisms by which sialylated milk oligosaccharides impact bone biology in a
gnotobiotic mouse model of infant undernutrition.
102. Evidence-based interventions for improvement of maternal and child nutrition in
low-income settings: what's new?
104. Effect of intestinal microbial ecology on the developing brain.
Supplements on the Growth and Development of Stunted Children in Uganda:
A Randomized Trial Protocol (MAGNUS).
Malawian children.
108. Dietary Cellulose Supplementation Modulates the Immune Response in a Murine
Endotoxemia Model.
109. Rice bran supplementation modulates growth, microbiota and metabolome in
weaning infants: a clinical trial in Nicaragua and Mali.
112. The Influence of Cesarean Section on the Composition and Development
of Gut Microbiota During the First 3 Months of Life.
113. Field evaluation of the gut microbiome composition of pre-school and school-
aged children in Tha Song Yang, Thailand, following oral MDA for STH
infections.
114. Campylobacter jejuni and associated immune mechanisms: short-term effects and
long-term implications for infants in low-income countries.
118. Clostridium Bacteria and Autism Spectrum Conditions: A Systematic Review and
Hypothetical Contribution of Environmental Glyphosate Levels.
120. Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or
inflammatory bowel disease?
121. Sex dependent effects of post-natal penicillin on brain, behavior and immune
regulation are prevented by concurrent probiotic treatment.
125. Distinct Microbiome-Neuroimmune Signatures Correlate With Functional
Abdominal Pain in Children With Autism Spectrum Disorder.
130. Epigenetic Influences on Neurodevelopment at 11 Years of Age: Protocol for the
Longitudinal Peri/Postnatal Epigenetic Twins Study at 11 Years of Age
(PETS@11).
132. Adaptation of commensal proliferating Escherichia coli to the intestinal tract of
young children with cystic fibrosis.
133. Association between extrauterine growth restriction and changes of intestinal
flora in Chinese preterm infants.
134. High-methionine diet in skeletal muscle remodeling: epigenetic mechanism of
homocysteine-mediated growth retardation.
136. Common beans and cowpeas as complementary foods to reduce environmental
enteric dysfunction and stunting in Malawian children: study protocol for two
randomized controlled trials.
138. Neonatal antibiotic exposure impairs child growth during the first six years of life
by perturbing intestinal microbial colonization.
141. Functional Bowel Disorders Are Associated with a Central Immune Activation.
142. Assessment of Environmental Enteric Dysfunction in the SHINE Trial: Methods
and Challenges.
143. Increased Urinary Trimethylamine N-Oxide Following Cryptosporidium Infection
and Protein Malnutrition Independent of Microbiome Effects.
144. Etiology of Diarrhea, Nutritional Outcomes, and Novel Intestinal Biomarkers in
Tanzanian Infants.
147. Case-Control Microbiome Study of Chronic Otitis Media with Effusion
in Children Points at Streptococcus salivarius as a Pathobiont-Inhibiting Species.
DATABASE PUBMED
(MICROBIOTA CHILDREN STUNTED)
3. Microbiota Transfer Therapy alters gut ecosystem and improves
gastrointestinal and autism symptoms: an open-label study.
4. Dynamics and Stabilization of the Human Gut Microbiome during the First
Year of Life.
5. Gut bacteria that prevent growth impairments transmitted by microbiota from
malnourished children.
7. Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art
Review.
8. Environmental Enteric Dysfunction and Growth Failure/Stunting in
Global Child Health.
11. Gut microbiota profile of Indonesian stunted children and children with
normal nutritional status.
13. Microbiota and neurodevelopmental windows: implications for
brain disorders.
14. Immunoglobulin recognition of fecal bacteria in stunted and non-
stunted children: findings from the Afribiota study.
17. Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-
Lung Triangle.
microbiome.
Reply.
24. AGA Technical Review on the Role of Probiotics in the Management of
Gastrointestinal Disorders.
26. Gut microbiota: stunted gut microbiota development persists after therapeutic
food interventions in children with severe acute malnutrition.
27. Intervention strategies for cesarean section-induced alterations in
the microbiota-gut-brain axis.
31. Gut-Amygdala Interactions in Autism Spectrum Disorders: Developmental
Roles via regulating Mitochondria, Exosomes, Immunity and microRNAs.
33. Dysbiotic microbiota in autistic children and their mothers: persistence of
fungal and bacterial wall-deficient L-form variants in blood.
34. Fecal microbiota analysis of children with small intestinal bacterial
overgrowth among residents of an urban slum in Brazil.
countries.
36. Measuring Artificial Sweeteners Toxicity Using a Bioluminescent Bacterial
Panel.
37. Decreased maternal serum acetate and impaired fetal thymic and regulatory T
cell development in preeclampsia.
38. The MAL-ED study: a multinational and multidisciplinary approach to
understand the relationship between enteric pathogens, malnutrition, gut
physiology, physical growth, cognitive development, and immune responses in
infants and children up to 2 years of age in resource-poor environments.
39. Environmental Enteric Dysfunction and the Fecal Microbiota in
Malawian Children.
45. Intestinal Microbiota in Common Chronic
Inflammatory Disorders Affecting Children.
diseases.
53. The Microbiota and Malnutrition: Impact of Nutritional Status During Early
Life.
56. Microbiome: Eating for trillions.
57. Stunting Is Preceded by Intestinal Mucosal Damage and Microbiome Changes
and Is Associated with Systemic Inflammation in a Cohort of Peruvian Infants.
58. Stunted childhood growth is associated with decompartmentalization of the
gastrointestinal tract and overgrowth of oropharyngeal taxa.
61. The effect of dietary resistant starch type 2 on the microbiota and markers of
gut inflammation in rural Malawi children.
therapeutics.
64. Fructose malabsorption syndrome.
65. A Retrospective Case-Control Study of the Relationship between the
Gut Microbiota, Enteropathy, and Child Growth.
66. Environmental enteric dysfunction and growth.
68. Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC
2015) : Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015.
71. What's eating you? An update on Giardia, the microbiome and the immune
response.
73. Environmental enteric dysfunction pathways and child stunting: A systematic
review.
75. Gut microbiota dysbiosis is associated with malnutrition and reduced plasma
amino acid levels: Lessons from genome-scale metabolic modeling.
82. Gut microbiota alterations and dietary modulation in childhood malnutrition -
The role of short chain fatty acids.
84. Early-life enteric infections: relation between chronic systemic inflammation
and poor cognition in children.
Undernutrition.
87. Co-occurrence of Campylobacter Species in Children From Eastern Ethiopia,
and Their Association With Environmental Enteric Dysfunction, Diarrhea, and
Host Microbiome.
dimorphic.
92. Association of faecal pH with childhood stunting: Results from a cross-
sectional study.
93. Proof-of-concept study of the efficacy of a microbiota-directed complementary
food formulation (MDCF) for treating moderate acute malnutrition.
Supplements on the Growth and Development of Stunted Children in Uganda:
A Randomized Trial Protocol (MAGNUS).
97. Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples
of Children with Suspected or Diagnosed Autism Spectrum Disorders and In
Malawian children.
101. Animal Models of Undernutrition and Enteropathy as Tools for Assessment of
Nutritional Intervention.
102. Gut Microbiota Features Associated With Campylobacter Burden and
Postnatal Linear Growth Deficits in a Peruvian Birth Cohort.
103. Mechanisms by which sialylated milk oligosaccharides impact bone biology in
a gnotobiotic mouse model of infant undernutrition.
104. Hygiene and other early childhood influences on the subsequent function of
the immune system.
105. Assessment of Neonatal Intensive Care Unit Practices and Preterm Newborn
Gut Microbiota and 2-Year Neurodevelopmental Outcomes.
107. Pathobiome driven gut inflammation in Pakistani children with
Environmental Enteric Dysfunction.
111. Evidence-based interventions for improvement of maternal and child nutrition
in low-income settings: what's new?
113. Campylobacter jejuni and associated immune mechanisms: short-term effects
and long-term implications for infants in low-income countries.
115. Neonatal Enteropathogenic Escherichia coli Infection Disrupts Microbiota-
Gut-Brain Axis Signaling.
117. The effect of bovine colostrum/egg supplementation compared with corn/soy
flour in young Malawian children: a randomized, controlled clinical trial.
118. Sex dependent effects of post-natal penicillin on brain, behavior and immune
regulation are prevented by concurrent probiotic treatment.
120. Effects of a Synbiotic Formula on Functional Bowel Disorders and
Gut Microbiota Profile during Long-Term Home Enteral Nutrition (LTHEN):
A Pilot Study.
124. Clostridium Bacteria and Autism Spectrum Conditions: A Systematic Review
and Hypothetical Contribution of Environmental Glyphosate Levels.
127. Common beans and cowpeas as complementary foods to reduce
environmental enteric dysfunction and stunting in Malawian children: study
protocol for two randomized controlled trials.
130. Dietary Cellulose Supplementation Modulates the Immune Response in a
Murine Endotoxemia Model.
131. Association between extrauterine growth restriction and changes of intestinal
flora in Chinese preterm infants.
136. Pediatric small intestine bacterial overgrowth in low-income countries.
137. High-methionine diet in skeletal muscle remodeling: epigenetic mechanism of
homocysteine-mediated growth retardation.
139. Protein Malnutrition Modifies Innate Immunity and Gene Expression by
Intestinal Epithelial Cells and Human Rotavirus Infection in Neonatal
Gnotobiotic Pigs.
141. It's in the Milk: Feeding the Microbiome to Promote Infant Growth.
142. Severe gut microbiota dysbiosis caused by malnourishment can be partly
restored during 3 weeks of refeeding with fortified corn-soy-blend in a piglet
model of childhood malnutrition.
146. Influence of Socio-Economic and Psychosocial Profiles on the Human Breast
Milk Bacteriome of South African Women.
147. Adaptation of commensal proliferating Escherichia coli to the intestinal tract
of young children with cystic fibrosis.
148. Dietary modulation of the microbiome affects autoinflammatory disease.
149. Prevalence of autoantibodies against some selected growth and appetite-
regulating neuropeptides in serum of short children exposed to Candida
albicans colonization and/or Helicobacter pylori infection: the molecular
mimicry phenomenon.
150. Functional Bowel Disorders Are Associated with a Central Immune
Activation.
151. Prevalence and antimicrobial resistance profiles of respiratory microbial flora
in African children with HIV-associated chronic lung disease.
152. Neonatal antibiotic exposure impairs child growth during the first six years of
life by perturbing intestinal microbial colonization.
153. Increased Urinary Trimethylamine N-Oxide Following Cryptosporidium
Infection and Protein Malnutrition Independent of Microbiome Effects.
154. Critical Role of Zinc in a New Murine Model of Enterotoxigenic Escherichia
coli Diarrhea.
155. Assessment of Environmental Enteric Dysfunction in the SHINE Trial:
Methods and Challenges.
156. Long-term safety of early consumption of Lactobacillus fermentum
CECT5716: A 3-year follow-up of a randomized controlled trial.
157. Etiology of Diarrhea, Nutritional Outcomes, and Novel Intestinal Biomarkers
in Tanzanian Infants.
158. Epigenetic Influences on Neurodevelopment at 11 Years of Age: Protocol for
the Longitudinal Peri/Postnatal Epigenetic Twins Study at 11 Years of Age
(PETS@11).
160. Risk factors for noma disease: a 6-year, prospective, matched case-control
study in Niger.
164. Environmental enteric dysfunction induces regulatory T cells that inhibit local
CD4+ T cell responses and impair oral vaccine efficacy.
DATABASE PUBMED
COMPOSITION MICROBIOTA STUNTED

1. Stunted microbiota and opportunistic pathogen colonization in caesarean-section
birth.
2. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and
autism symptoms: an open-label study.
3. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of
Life.
4. Influence of gut microbiota on neuropsychiatric disorders.
5. A purified membrane protein from Akkermansia muciniphila or the pasteurized
bacterium improves metabolism in obese and diabetic mice.
7. Modulation of Gut Microbiota Composition by Serotonin Signaling Influences
Intestinal Immune Response and Susceptibility to Colitis.
9. The Relationship Between the Serotonin Metabolism, Gut-Microbiota and the Gut-
Brain Axis.
10. The role of the gut microbiota in development, function and disorders of the central
nervous system and the enteric nervous system.
11. Potential benefits of colostrum in gastrointestinal diseases.
12. Early nutrition and gut microbiome: interrelationship between bacterial metabolism,
immune system, brain structure, and neurodevelopment.
microbiome.
14. The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular
disease.
15. Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-Lung
Triangle.
16. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-
obesity effects of polysaccharides isolated from Hirsutella sinensis.
17. Prebiotics and Community Composition Influence Gas Production of the Human
Gut Microbiota.
18. Factors affecting the composition of the gut microbiota, and its modulation.
19. An increase in the Akkermansia spp. population induced by metformin treatment
improves glucose homeostasis in diet-induced obese mice.
20. Gut microbiota remodeling reverses aging-associated inflammation and
dysregulation of systemic bile acid homeostasis in mice sex-specifically.
21. Altered diversity and composition of gut microbiota in Wilson's disease.
23. A distinct gut microbiota composition in patients with ankylosing spondylitis is
associated with increased levels of fecal calprotectin.
24. Neohesperidin attenuates obesity by altering the composition of the
gut microbiota in high-fat diet-fed mice.
25. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese
mice.
26. Intestinal microbiota, diet and health.
27. Evidence of altered mucosa-associated and fecal microbiota composition in patients
with Irritable Bowel Syndrome.
28. Gut microbiota: puppeteer of the host juvenile growth.
30. Longitudinal Analysis of the Intestinal Microbiota in Persistently Stunted Young
Children in South India.
31. Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic
steatohepatitis in Western diet-fed mice.
32. Impact of vitamin deficiency on microbiota composition and immunomodulation:
relevance to autistic spectrum disorders.
33. Gut microbiota profile of Indonesian stunted children and children with normal
nutritional status.
34. Antibiotics in early life and obesity.
35. Dysbiosis in Functional Bowel Disorders.
36. Maternal and infant factors that shape neonatal gut colonization by bacteria.
diseases.
40. Non-Melanoma Skin Cancer: news from microbiota research.
41. The Microbiota and Malnutrition: Impact of Nutritional Status During Early Life.
43. Interactions of probiotics and prebiotics with the gut microbiota.
44. Programming Bugs: Microbiota and the Developmental Origins of Brain Health and
Disease.
45. Carbohydrates and the human gut microbiota.
46. Beneficial Effects of Non-Encapsulated or Encapsulated Probiotic Supplementation
on Microbiota Composition, Intestinal Barrier Functions, Inflammatory Profiles, and
Glucose Tolerance in High Fat Fed Rats.
47. Upper gastrointestinal microbiota and digestive diseases.
48. [Changes in the composition of intestinal microbiota in mice with acute liver failure
induced by D-galactosamine].
50. Staphylococcus aureus and the Cutaneous Microbiota Biofilms in the Pathogenesis of
Atopic Dermatitis.
51. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and alters
gut microbiota composition in hyperlipidemic mice fed a high-fat diet.
52. [Current view on gut microbiota].
53. The role of prebiotics in cognition, anxiety, and depression.
54. Disrupted tongue microbiota and detection of nonindigenous bacteria on the day of
allogeneic hematopoietic stem cell transplantation.
55. The gut microflora assay in patients with colorectal cancer: in feces or tissue samples?
56. The gut microbiome.
57. Standardized Preparation for Fecal Microbiota Transplantation in Pigs.
59. Does the Oral Microbiome Play a Role in Hypertensive Pregnancies?
60. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in
response of colocytes.
61. Green Tea Encourages Growth of Akkermansia muciniphila.
63. Amino Acids Regulate Glycolipid Metabolism and Alter Intestinal
Microbial Composition.
64. Voices from within: gut microbes and the CNS.
65. Early-life malnutrition causes gastrointestinal dysmotility that is sexually dimorphic.
66. Gut microbiota alterations and dietary modulation in childhood malnutrition - The
role of short chain fatty acids.
68. Nutrients Mediate Bioavailability and Turnover of Proteins in Mammals.
70. Bacterial skin commensals and their role as host guardians.
71. Recipe for a Healthy Gut: Intake of Unpasteurised Milk Is Associated with
Increased Lactobacillus Abundance in the Human Gut Microbiome.
72. Microbiomes Reduce Their Host's Sensitivity to Interspecific Interactions.
73. The Gut Microbiota: A Promising Target in the Relation between Complementary
Feeding and Child Undernutrition.
74. Dietary iron variably modulates assembly of the intestinal microbiota in colitis-
resistant and colitis-susceptible mice.
76. Mechanisms and effectiveness of prebiotics in modifying the
gastrointestinal microbiota for the management of digestive disorders.
77. Microbiota and Neurodevelopmental Trajectories: Role of Maternal and Early-Life
Nutrition.
78. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by
modulating gut microbiota, improving intestinal barrier integrity, and attenuating
inflammation.
79. Study of the fetal and maternal microbiota in pregnant women with
intrauterine growth restriction and its relationship with inflammatory biomarkers: A
case-control study protocol (SPIRIT compliant).
80. Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease.
81. Radiomicrobiomics: Advancing Along the Gut-brain Axis Through Big Data
Analysis.
82. A Retrospective Case-Control Study of the Relationship between the Gut Microbiota,
Enteropathy, and Child Growth.
83. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
84. Huai hua san alleviates dextran sulphate sodium-induced colitis and modulates
colonic microbiota.
85. Microbial insight into dietary protein source affects intestinal function of pigs with
intrauterine growth retardation.
86. Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting
Children.
87. Gut microbiota controls adipose tissue expansion, gut barrier and glucose
metabolism: novel insights into molecular targets and interventions using prebiotics.
88. [The value of mucosal small intestine microbiota in digestion and
absorption disorders in metabolic syndrome].
89. Dental biofilm and its ecological interrelationships in ovine periodontitis.
90. Stunting Is Preceded by Intestinal Mucosal Damage and Microbiome Changes and Is
Associated with Systemic Inflammation in a Cohort of Peruvian Infants.
91. Effects of subchronic exposure of mercuric chloride on intestinal histology
and microbiota in the cecum of chicken.
92. Scalp bacterial shift in Alopecia areata.
93. Enduring Behavioral Effects Induced by Birth by Caesarean Section in the Mouse.
94. Analysis of temporal fecal microbiota dynamics in weaner pigs with and without
exposure to enterotoxigenic Escherichia coli1,2.
95. Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for
Diagnosis and Treatment.
96. Giardia duodenalis induces pathogenic dysbiosis of human
intestinal microbiota biofilms.
97. Alterations in the Urinary Microbiota Are Associated With Cesarean Delivery.
98. Differences in immune status and fecal SCFA between Indonesian stunted children
and children with normal nutritional status.
99. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or
faecal transplantation?
100. Overgrowth of the indigenous gut microbiome and irritable bowel syndrome.
101. Environmental Chemical Diethylhexyl Phthalate Alters
Intestinal Microbiota Community Structure and Metabolite Profile in Mice.
intestinal microbiota: Implications for children in low- and middle-income countries.
103. Gut microbiota of newborn piglets with intrauterine growth restriction have lower
diversity and different taxonomic abundances.
105. [Role of the microbiome in chronic wounds].
106. Food restriction followed by refeeding with a casein- or whey-based diet differentially
affects the gut microbiota of pre-pubertal male rats.
107. Absence of gut microbiota influences lipopolysaccharide-induced behavioral changes
in mice.
110. Lactobacillus casei improves depression-like behavior in chronic unpredictable mild
stress-induced rats by the BDNF-TrkB signal pathway and the intestinal microbiota.
111. Compound Lactobacillus sp. administration ameliorates stress and
body growth through gut microbiota optimization on weaning piglets.
112. Identifying the etiology and pathophysiology underlying stunting and environmental
enteropathy: study protocol of the AFRIBIOTA project.
113. Effects of Dietary Interventions on Gut Microbiota in Humans and the Possible
Impacts of Foods on Patients' Responses to Cancer Immunotherapy.
114. Gut Microbiota Features Associated With Campylobacter Burden and Postnatal
Linear Growth Deficits in a Peruvian Birth Cohort.
115. Intestinal dysbiosis: an emerging cause of pregnancy complications?
116. beta-Carotene prevents weaning-induced intestinal inflammation by modulating
gut microbiota in piglets.
117. Interactions of Dietary Fibre with Nutritional Components on Gut
Microbial Composition, Function and Health in Monogastrics.
118. Intestinal response characteristic and potential microbial dysbiosis in digestive tract of
Bufo gargarizans after exposure to cadmium and lead, alone or combined.
119. Amino acid metabolism in intestinal bacteria and its potential implications for
mammalian reproduction.
120. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and
Expectations for Gut Microbiome Transplantation.
121. Alterations in the Vaginal Microbiome by Maternal Stress Are Associated With
Metabolic Reprogramming of the Offspring Gut and Brain.
123. Generation of axenic Aedes aegypti demonstrate live bacteria are not required for
mosquito development.
124. Gut microbiota profiles of young South Indian children: Child sex-specific relations
with growth.
125. The composition and structure of the intestinal microflora of Anguilla marmorata at
different growth rates: a deep sequencing study.
126. Antioxidant properties of formula derived Maillard reaction products in colons of
intrauterine growth restricted pigs.
127. Medicinal lavender modulates the enteric microbiota to protect against Citrobacter
rodentium-induced colitis.
128. Endocrine disrupting chemicals and metabolic disorders in the liver: What if we also
looked at the female side?
129. Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of
Cyclooxygenase-2 by Rofecoxib in the Rat.
130. Early life nutrition influences susceptibility to chronic inflammatory colitis in later
life.
131. Unraveling the Complexity of Soil Microbiomes in a Large-Scale Study Subjected to
Different Agricultural Management in Styria.
132. Fat binding capacity and modulation of the gut microbiota both determine the effect
of wheat bran fractions on adiposity.
133. Perturbations of gut microbiome genes in infants with atopic dermatitis according to
feeding type.
134. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and
psychological abnormalities in rats.
135. Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association
with modulation of gut microbiota in mice.
136. Fecal microbiota analysis of children with small intestinal bacterial overgrowth
among residents of an urban slum in Brazil.
137. A postbiotic consisting of heat-treated lactobacilli has a bifidogenic effect in pure
culture and in human fermented faecal communities.
138. Flaxseed oil supplementation improves intestinal function and immunity, associated
with altered intestinal microbiome and fatty acid profile in pigs with
intrauterine growth retardation.
139. Lactococcus lactis and Resveratrol Decrease Body Weight and Increase Benefic
Gastrointestinal Microbiota in Mice.
140. Bacterial sensing underlies artificial sweetener-induced growth of gut Lactobacillus.
141. The Impact of Gut Microbiome on Metabolic Disorders During Catch-Up Growth in
Small-for-Gestational-Age.
142. Predictive Metagenomic Profiling, Urine Metabolomics, and Human Marker Gene
Expression as an Integrated Approach to Study Alopecia Areata.
143. Impact of dietary induced precocious gut maturation on cecal microbiota and its
relation to the blood-brain barrier during the postnatal period in rats.
144. Neonatal environment exerts a sustained influence on the development of the
intestinal microbiota and metabolic phenotype.
145. Colonization with the enteric protozoa Blastocystis is associated with increased
diversity of human gut bacterial microbiota.
147. Changes in microbial ecology after fecal microbiota transplantation for recurrent C.
difficile infection affected by underlying inflammatory bowel disease.
148. Co-occurrence of Campylobacter Species in Children From Eastern Ethiopia, and
Their Association With Environmental Enteric Dysfunction, Diarrhea, and Host
Microbiome.
149. Bacterial Diversity of Intestinal Microbiota in Patients with Substance
Use Disorders Revealed by 16S rRNA Gene Deep Sequencing.
150. Nutritional impact on health and performance in intensively reared rabbits.
151. Assessment of Environmental Enteric Dysfunction in the SHINE Trial: Methods and
Challenges.
153. Examination of Host Phenotypes in Gambusia affinis Following Antibiotic Treatment.
154. Could Nodding Syndrome (NS) in Northern Uganda be an environmentally induced
alteration of ancestral microbiota?
155. Prenatal stress affects placental cytokines and neurotrophins, commensal microbes,
and anxiety-like behavior in adult female offspring.
156. Inulin Supplementation Lowered the Metabolic Defects of Prolonged Exposure to
Chlorpyrifos from Gestation to Young Adult Stage in Offspring Rats.
157. The effect of dietary resistant starch type 2 on the microbiota and markers of gut
inflammation in rural Malawi children.
158. Bacterial Succession in the Broiler Gastrointestinal Tract.
159. Relative abundance of Akkermansia spp. and other bacterial phylotypes correlates
with anxiety- and depressive-like behavior following social defeat in mice.
160. Role of Helicobacter pylori and Other Environmental Factors in the Development of
Gastric Dysbiosis.
161. Intestinal fluke Metagonimus yokogawai infection increases probiotic Lactobacillus
in mouse cecum.
162. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome
and modulates the fecal microbiota and immune function of overweight adults.
163. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic
sensory and motor changes in mice.
164. The Role of Milk Protein and Whey Permeate in Lipid-based Nutrient Supplements
on the Growth and Development of Stunted Children in Uganda: A Randomized
Trial Protocol (MAGNUS).
165. Potential role of weather, soil and plant microbial communities in rapid decline of
apple trees.
166. Impact of feed restriction and housing hygiene conditions on specific and
inflammatory immune response, the cecal bacterial community and the survival of
young rabbits.
167. Copper-induced sublethal effects in Bufo gargarizans tadpoles: growth, intestinal
histology and microbial alternations.
168. Chinese liver fluke Clonorchis sinensis infection changes the gut microbiome and
increases probiotic Lactobacillus in mice.
169. Gut microbiome composition is linked to whole grain-induced immunological
improvements.
170. The Effect of Administration of a Phytobiotic Containing Cinnamon Oil and Citric
Acid on the Metabolism, Immunity, and Growth Performance of Broiler Chickens.
171. Does Dysbiosis Increase the Risk of Developing Schizophrenia? - A Comprehensive
Narrative Review.
172. Influence of Socio-Economic and Psychosocial Profiles on the Human Breast Milk
Bacteriome of South African Women.
173. A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic
Activity of Butyrate-Producing Bacteria in Faecal Samples.
174. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin
resistance in association with modulation of gut microbiota in mice.
175. COLOSTRO NONI administration effects on epithelial cells turn-over, inflammatory
events and integrity of intestinal mucosa junctional systems.
176. Wheat bran extract alters colonic fermentation and microbial composition, but does
not affect faecal water toxicity: a randomised controlled trial in healthy subjects.
177. Study of Environmental Enteropathy and Malnutrition (SEEM) in Pakistan: protocols
for biopsy based biomarker discovery and validation.
178. Influence of Feeding Omega-3 Polyunsaturated Fatty Acids to Broiler Breeders on
Indices of Immunocompetence, Gastrointestinal, and Skeletal Development in Broiler
Chickens.
179. Impact of feed restriction on health, digestion and faecal microbiota of growing pigs
housed in good or poor hygiene conditions.
180. Sodium butyrate alleviates cholesterol gallstones by regulating bile acid metabolism.
181. Dietary squid ink polysaccharides ameliorated the intestinal microflora dysfunction in
mice undergoing chemotherapy.
182. Adverse effect of early-life high-fat/high-carbohydrate ("Western") diet on bacterial
community in the distal bowel of mice.
183. Diversity of bacterial communities on the facial skin of different age-group Thai
males.
184. Effects of the Dietary Protein and Carbohydrate Ratio on Gut Microbiomes in Dogs
of Different Body Conditions.
185. Remnant Small Bowel Length in Pediatric Short Bowel Syndrome and the Correlation
with Intestinal Dysbiosis and Linear Growth.
186. Diabetic cognitive dysfunction is associated with increased bile acids in liver and
activation of bile acid signaling in intestine.
187. Effects of S24-7 on the weight of progeny rats after exposure to ceftriaxone sodium
during pregnancy.
188. Excessive Unbalanced Meat Consumption in the First Year of Life Increases Asthma
Risk in the PASTURE and LUKAS2 Birth Cohorts.
189. Size-dependent adverse effects of microplastics on intestinal microbiota and
metabolic homeostasis in the marine medaka (Oryzias melastigma).
190. Colonic inflammation accompanies an increase of β-catenin signaling and
Lachnospiraceae/Streptococcaceae bacteria in the hind gut of high-fat diet-fed mice.
191. Changes in the intestinal bacterial community, short-chain fatty acid profile, and
intestinal development of preweaned Holstein calves. 1. Effects of prebiotic
supplementation depend on site and age.

1.database Pubmed

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

1.database Pubmed

Uploaded by

Copyright:

Available Formats

DATABASE PUBMED

1. Influence of gut microbiota on neuropsychiatric disorders.

COMPOSITION MICROBIOTA STUNTED

You might also like